ALKS - Alkermes Non-GAAP EPS of $0.22 misses by $0.24 revenue of $377.5M beats by $15.13M
2024-02-15 07:07:23 ET
More on Alkermes
- Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage
- Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet
- Alkermes Q4 2023 Earnings Preview
- Alkermes to sell Athlone facility in Ireland to Novo Nordisk for $92.5M
- Seeking Alpha’s Quant Rating on Alkermes